Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Nov;14(11):e70068.
doi: 10.1002/ctm2.70068.

Confirmation of previously identified plasma microRNA ratios for breast cancer detection in a nested case-control study within a screening setting

Affiliations

Confirmation of previously identified plasma microRNA ratios for breast cancer detection in a nested case-control study within a screening setting

Emir Sehovic et al. Clin Transl Med. 2024 Nov.
No abstract available

PubMed Disclaimer

Figures

FIGURE 1
FIGURE 1
Flowchart of the pipeline in which we assessed the discrimination power and calibration of the model on miRNA ratios and nonmolecular variables. *let‐7b‐5p was replaced by let‐7a‐5p in the ratios, due to a high correlation (ρ = .96) of Cts between the two miRNAs within the discovery set and as their mature sequences are almost identical (two nucleotides are different).
FIGURE 2
FIGURE 2
ROC AUC (A) based on the ridge regression on the model with all predictors. Within the ROC curve, the Youden's cut‐off and AUC are reported. (B) Histogram of bootstrapped (2000 sampling iterations) ROC AUC based on the ridge regression. The vertical dashed line represents the ROC AUC obtained in the ridge logistic regression model on the original validation sample. (C) Calibration plot of the ridge regression model on all predictors where the intercept and slope of the calibration curve and the c statistic are shown.

References

    1. Sehovic E, Urru S, Chiorino G, Doebler P. Meta‐analysis of diagnostic cell‐free circulating microRNAs for breast cancer detection. BMC Cancer. 2022;22:634. - PMC - PubMed
    1. Giordano L, Gallo F, Petracci E, Chiorino G, Segnan N, the Andromeda working group . The ANDROMEDA prospective cohort study: predictive value of combined criteria to tailor breast cancer screening and new opportunities from circulating markers: study protocol. BMC Cancer. 2017;17:785. - PMC - PubMed
    1. Chiorino G, Petracci E, Sehovic E, et al. Plasma microRNA ratios associated with breast cancer detection in a nested case–control study from a mammography screening cohort. Sci Rep. 2023;13:12040. - PMC - PubMed
    1. Koi Y, Tsutani Y, Nishiyama Y, et al. Predicting the presence of breast cancer using circulating small RNAs, including those in the extracellular vesicles. Cancer Sci. 2020;111:2104‐2115. - PMC - PubMed
    1. Aggarwal V, Priyanka K, Tuli HS. Emergence of circulating MicroRNAs in breast cancer as diagnostic and therapeutic efficacy biomarkers. Mol Diagn Ther. 2020;24:153‐173. - PubMed

LinkOut - more resources